Over the past 12 months, 11 insiders at BridgeBio Pharma, Inc. filed 167 open-market SEC Form 4 transactions on BBIO: 0 purchases worth $0 and 167 sales worth $141.5M. Insiders have been net sellers over this period. The most recent filing was on Jul 9, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 26 | Jennifer E. Cook | SELL | 112.4K | $90.00 | $10.1M |
| Jul 9, 26 | Andrea Ellis | SELL | 17.2K | $84.00 | $1.4M |
| Jun 24, 26 | Jennifer E. Cook | SELL | 37.2K | $70.00 | $2.6M |
| Jun 23, 26 | Jennifer E. Cook | SELL | 2.2K | $68.57 | $151K |
| Jun 23, 26 | Hannah Valantine | SELL | 2.2K | $68.57 | $151K |
| Jun 22, 26 | Hannah Valantine | SELL | 2.8K | $68.00 | $191K |
| Jun 15, 26 | Jennifer E. Cook | SELL | 88.7K | $67.14 | $5.9M |
| Jun 5, 26 | Neil KumarChief Executive Officer | SELL | 8.4K | $68.96 | $573K |
| Jun 4, 26 | Neil KumarChief Executive Officer | SELL | 15.9K | $68.27 | $1.1M |
| May 21, 26 | Neil KumarChief Executive Officer | SELL | 11.3K | $70.92 | $793K |
| May 18, 26 | Thomas TrimarchiPresident and CFO | SELL | 10.5K | $65.95 | $678K |
| May 15, 26 | Randal W. Scott | SELL | 6.2K | $69.12 | $413K |
| May 8, 26 | Neil KumarChief Executive Officer | SELL | 14.0K | $68.35 | $931K |
| May 7, 26 | Neil KumarChief Executive Officer | SELL | 11.2K | $69.09 | $757K |
| Apr 30, 26 | Maricel ApuliChief Accounting Officer | SELL | 2.0K | $71.58 | $143K |
| Apr 10, 26 | Neil KumarChief Executive Officer | SELL | 20.0K | $74.60 | $1.5M |
| Apr 9, 26 | Neil KumarChief Executive Officer | SELL | 7.8K | $75.55 | $589K |
| Mar 13, 26 | Neil KumarChief Executive Officer | SELL | 10.3K | $69.23 | $713K |
| Mar 12, 26 | Neil KumarChief Executive Officer | SELL | 14.3K | $70.15 | $982K |
| Mar 10, 26 | Hannah ValantineDirector | SELL | 8.7K | $72.00 | $624K |
| Mar 4, 26 | Andrea EllisDirector | SELL | 64.9K | $64.87 | $4.2M |
| Feb 27, 26 | Hannah ValantineDirector | SELL | 14.6K | $67.84 | $978K |
| Feb 26, 26 | Maricel ApuliChief Accounting Officer | SELL | 2.0K | $66.00 | $132K |
| Feb 19, 26 | Neil KumarChief Executive Officer | SELL | 18.9K | $72.80 | $1.3M |
| Feb 17, 26 | Randal W. ScottDirector | SELL | 4.8K | $75.93 | $362K |
| Feb 17, 26 | Maricel ApuliChief Accounting Officer | SELL | 510 | $74.31 | $38K |
| Feb 17, 26 | Thomas TrimarchiPresident and CFO | SELL | 13.4K | $75.38 | $1.0M |
| Feb 11, 26 | Neil KumarChief Executive Officer | SELL | 7.9K | $73.25 | $556K |
| Feb 10, 26 | Neil KumarChief Executive Officer | SELL | 14.2K | $72.28 | $1.0M |
| Jan 9, 26 | Neil KumarChief Executive Officer | SELL | 10.7K | $78.19 | $827K |
| Jan 8, 26 | Neil KumarChief Executive Officer | SELL | 11.6K | $75.20 | $852K |
| Dec 15, 25 | Neil KumarChief Executive Officer | SELL | 28.3K | $75.24 | $2.1M |
| Dec 8, 25 | Maricel ApuliChief Accounting Officer | SELL | 2.0K | $74.26 | $149K |
| Dec 5, 25 | Neil KumarChief Executive Officer | SELL | 12.5K | $73.76 | $914K |
| Dec 4, 25 | Neil KumarChief Executive Officer | SELL | 12.2K | $74.80 | $908K |
| Nov 20, 25 | Neil KumarChief Executive Officer | SELL | 14.3K | $66.71 | $942K |
| Nov 18, 25 | Andrew LoDirector | SELL | 31.0K | $66.05 | $2.0M |
| Nov 17, 25 | Andrew LoDirector | SELL | 36.8K | $67.06 | $2.5M |
| Nov 17, 25 | Randal W. ScottDirector | SELL | 6.2K | $66.89 | $415K |
| Nov 17, 25 | Thomas TrimarchiPresident and CFO | SELL | 10.0K | $66.84 | $660K |
| Nov 12, 25 | Hannah ValantineDirector | SELL | 25.5K | $66.07 | $1.7M |
| Nov 7, 25 | Neil KumarChief Executive Officer | SELL | 12.5K | $62.81 | $764K |
| Nov 6, 25 | Ronald J DanielsDirector | SELL | 61.0K | $63.72 | $3.9M |
| Nov 6, 25 | Neil KumarChief Executive Officer | SELL | 12.6K | $64.39 | $791K |
| Oct 29, 25 | Frank McCormickDirector | SELL | 111.8K | $69.24 | $7.3M |
| Oct 27, 25 | Frank McCormickDirector | SELL | 1.6K | $65.00 | $107K |
| Oct 9, 25 | Neil KumarChief Executive Officer | SELL | 20.0K | $54.80 | $1.1M |
| Oct 8, 25 | Neil KumarChief Executive Officer | SELL | 11.3K | $55.09 | $622K |
| Sep 5, 25 | Frank McCormickDirector | SELL | 74.0K | $53.16 | $3.9M |
| Sep 5, 25 | Neil KumarChief Executive Officer | SELL | 16.9K | $53.80 | $898K |
Over the past 12 months, insiders at BridgeBio Pharma, Inc. filed 0 open-market purchases worth $0 and 167 sales worth $141.5M on BBIO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 9, 26.
11 different insiders at BridgeBio Pharma, Inc. filed open-market SEC Form 4 transactions on BBIO over the last 12 months.
InsiderTape plots every BBIO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every BridgeBio Pharma, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →